ANA Investigates Embolic Strokes of Undetermined Source
In this podcast, Hooman Kamel, MD, talks about embolic strokes of undetermined source (ESUS), the current standard of care for diagnosing and treating ESUS, and the evolution of research around ESUS.
Hooman Kamel, MD, is chief of the Division of Neurocritical Care and director of the Clinical and Translational Neuroscience Unit in the Department of Neurology and the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine in New York, New York.
Published in partnership with
For more ANA investigates podcasts, visit our partners at the American Neurological Association.